CompletedPhase 2NCT00004665

Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

Studying Systemic lupus erythematosus

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Center for Research Resources (NCRR)
Principal Investigator
Rosalind Ramsey-Goldman, MD
Northwestern University
Intervention
dehydroepiandrosterone(drug)
Enrollment
20 enrolled
Eligibility
18 years · FEMALE
Timeline
1995

Collaborators

Northwestern University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004665 on ClinicalTrials.gov

Other trials for Systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Systemic lupus erythematosus

← Back to all trials